Systematic Financial Management LP Supernus Pharmaceuticals, Inc. Transaction History
Systematic Financial Management LP
- $3.39 Billion
- Q1 2025
A detailed history of Systematic Financial Management LP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Systematic Financial Management LP holds 166,504 shares of SUPN stock, worth $5.49 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
166,504
Previous 113,500
46.7%
Holding current value
$5.49 Million
Previous $4.1 Million
32.87%
% of portfolio
0.16%
Previous 0.11%
Shares
9 transactions
Others Institutions Holding SUPN
# of Institutions
305Shares Held
60.8MCall Options Held
8.8KPut Options Held
6.3K-
Black Rock Inc. New York, NY10.4MShares$343 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.16MShares$203 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$171 Million2.59% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.9MShares$95.7 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.7MShares$89 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.76B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...